Using HFD‐induced NAFLD mice, Li et al. (2018) showed a significant association between lycopene intake and reduced severity of hepatic steatosis, liver TG, expression of TNF‐α, IL‐6, and IL‐1. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.